We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00669929
Recruitment Status : Unknown
Verified February 2009 by Yonsei University.
Recruitment status was:  Recruiting
First Posted : May 1, 2008
Last Update Posted : February 19, 2009
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Severance Hospital
Information provided by:
Yonsei University

Brief Summary:
The primary objective of the proposed project is to estimate the economic impact of a national rotavirus immunization program in preventing rotavirus diarrhea among Korean children.

Condition or disease
Gastroenteritis Rotavirus Vaccines Cost-Effectiveness

Detailed Description:
Rotavirus is the leading cause of severe acute diarrhea or gastroenteritis among young children worldwide. In the first 5 years of life, about 90% of children experience at least one episode of rotavirus infection.Each year, rotavirus diarrhea is responsible for 440,000 deaths, 2 million hospitalizations, and 25 million outpatient visits among children younger than 5 years worldwide. In South Korea, rotavirus diarrhea rarely causes mortality, but it cause significant morbidity. A recent population-based study in Korea has estimated that the annual incidence of rotavirus diarrhea accounts for 56.9 cases per 1,000 children less than 5 years old. Oral, live pentavalent human-bovine reassortant rotavirus vaccine has been developed and licensed for the use of preventing rotavirus disease in many countries. Yet, there has been no research done to assess the impact of national rotavirus immunization program in Korea. It is expected that systematic appraisal on the national burden of rotavirus infection and potential public health and economic benefits of rotavirus vaccination for children in Korea will assists health policy makers to set a priority for the prevention of this disease.

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea
Study Start Date : May 2008
Estimated Primary Completion Date : June 2009
Estimated Study Completion Date : June 2009

Group/Cohort
1
patients visited to Severance hospital
2
patients visited to Youngdong Severance hospital
3
patients visited to Wonju Christian hospital



Primary Outcome Measures :
  1. patients' cost [ Time Frame: one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 5 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients to visit assigned hospital
Criteria

Inclusion Criteria:

  • children aged under 5 years and diagnosed as acute gastroenteritis

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00669929


Contacts
Contact: Dong Soo Kim, MD, PhD 82-2-2228-2005 dskim6634@yuhs.ac
Contact: Ki Hwan Kim, MD 82-2-2227-4188 khkim99@yuhs.ac

Locations
Korea, Republic of
Wonju Christian Hospital Recruiting
Wonju, Kangwon-do, Korea, Republic of
Contact: Hwang Min Kim, MD,PhD       khm9120@wonju.yonsei.ac.kr   
Sub-Investigator: Hwang Min Kim, MD,PhD         
Yonsei University Health System Severance Hospital Recruiting
Seoul, Korea, Republic of, 120-752
Contact: Dong Soo Kim, MD, PhD    82-2-2228-2005    dskim6634@yuhs.ac   
Contact: Ki Hwan Kim, MD    82-2-2227-4188    khkim99@yuhs.ac   
Principal Investigator: Dong Soo Kim, MD, PhD         
Sub-Investigator: Hye-Young Kang, PhD         
Sub-Investigator: Ki Hwan Kim, MD         
Youngdong Severance Hospital Recruiting
Seoul, Korea, Republic of
Contact: Ji Hong Kim, MD,PhD       kkkjhd@yuhs.ac   
Sub-Investigator: Ji Hong Kim, MD,PhD         
Sponsors and Collaborators
Yonsei University
Merck Sharp & Dohme Corp.
Severance Hospital
Investigators
Principal Investigator: Dong Soo Kim, MD, PhD professor